Skip to main content
search

D360

Data-driven drug discovery delivered

Shorten the design-make-test-analyze cycle with D360

Is your research informatics software designed to support an efficient drug discovery process? The D360 Scientific Informatics Platform is the industry-leading solution for small molecule and sequence-based modalities research, whose versatility and low total cost of ownership have made it the analysis and visualization system of choice for discovery teams globally. Designed to empower scientists, D360 offers seamless access to your enterprise data — from compound informatics and bioactivity parameters to operational data like inventory — along with integrated tools for visualization, analysis, and collaboration.

The result is an accelerated Design-Make-Test-Analyze cycle, informed by the best possible scientific decisions and operational efficiency. Trusted by top pharmaceutical companies and innovative biotechs, D360 is revolutionizing data-driven scientific research.

Accelerates the Design-Make-Test-Analyze cycle for drug discovery

More than 6,000 research scientists worldwide rely on D360

Trusted by the top 10 pharmaceutical companies globally

Empowering drug discovery with self-service data access and advanced analytics

D360 Scientific Informatics Platform revolutionizes drug discovery by offering unparalleled self-service data access and analysis capabilities. It integrates seamlessly with data sources, enabling scientists to create custom dashboards, automate data workflows, and visualize complex datasets with ease. Whether working with small molecules, antibodies, oligos, or any other modality, D360 ensures consistent data handling and analysis, empowering teams to make informed decisions faster.

Self-service data search with drag-and-drop interfaces and shareable queries.
Advanced visualization tools, including scatter plots, histograms, and clustering.
Supports research into small molecules, peptides, oligos, antibodies, ADCs and other modalities, combining general data analytics with structure and sequence-based analysis.

Why Certara

Certara delivers leading-edge solutions that empower scientists to make data-driven decisions, accelerating drug discovery timelines and improving outcomes.

  • Early drug discovery is a core area of expertise at Certara, supported by a team of highly experienced and renowned experts in the field.
  • The dynamic community of users from drug discovery empowers us to continuously refine our solutions to meet the ever-evolving demands of innovative research.

"D360 is saving us hundreds of hours annually on data analysis. That is an important contribution to our research. The Certara team is tenacious and resourceful. They always find a solution. That’s what has made our relationship so successful.”

Arvinas

Dr. Keith Hornberger
Director of Chemistry, Arvinas

Your data is safe with D360

At Certara, we prioritize the security of your valuable information assets. D360 is within the scope of Certara Software division’s ISO 27001 certification, ensuring robust security controls, confidentiality, and data integrity.

Schedule a demo

Schedule a demo today to see how D360 empowers your team with advanced data visualization, analysis, and collaboration tools.

Query research data efficiently across different data sources
Spend more time on science and less time on data wrangling
Make effective go/no-go decisions faster


FAQs

What types of data can D360 handle?

D360 supports chemical structure, sequence, and HELM representations for therapeutic modality structure/sequence including non-natural monomers. D360 supports all types of assay data for efficacy, selectivity, ADMET and PK data including rendering of Dose-response curves.

How does D360 facilitate collaboration between internal teams and external research partners?

D360 supports joint internal/external research teams through the D360 Partner add-on which provides query and annotation sharing with external research partners while ensuring data security. Learn more about D360 Partner.

Is D360 suitable for smaller pharmaceutical organizations with limited IT resources?

Because of its extremely low maintenance overhead and scalability, D360 is suitable for organizations ranging from top 10 multi-national, multi-site large pharmaceutical companies down to small biotechnology research organizations. D360 Express is tailored for smaller organizations offering quick deployment, pre-configured connectors, and a standard adoption plan. Learn more about D360 Express.

What integrations are available with D360 for enhanced research capabilities?

D360 integrates with leading tools such as Design Hub, Scilligence, CDD Vault, and Optibrium, offering comprehensive discovery informatics solutions. Learn more about our partners.

Can D360 be used programmatically?

Yes, D360 provides a rich array of REST services to allow programmatic query execution and data access for computational processes. This capability has grown significantly to feed D360 cleansed and aggregated data into AI and ML learning.